RESEARCH
[Publication] Microbiota-mediated Induction of Beige Adipocytes in Response to Dietary Cues
March 5, 2026
Fig. 1: LPDs induce browning in a microbiota-dependent manner.
Credits: 10.1038/s41586-026-10205-3
A research group led by Bio2Q Center Director Professor Kenya Honda has revealed how a low-protein diet induces energy-burning beige adipocytes via gut microbiota. The team identified four specific bacterial strains from humans that promote the “browning” of white adipose tissue. The study uncovered two key mechanisms: bile acid metabolism activating FXR and bacteria-derived ammonia triggering hepatic FGF21 expression. This evolutionary strategy for metabolic adaptation offers promising insights into treating obesity and type 2 diabetes through microbiome-based therapies. These groundbreaking findings were published in the journal Nature on March 4, 2026.
| Title | Microbiota-mediated induction of beige adipocytes in response to dietary cues |
|---|---|
| Authors | Takeshi Tanoue, Manabu Nagayama, Ayumi J.A. Roochana, Samuel Zimmerman, Orr Ashenberg, Tanvi Jain, Ryo Igarashi, Satoshi Sasajima, Kozue Takeshita, Nicola Hetherington, Nobuyuki Okahashi, Masahiro Ueda, Morichika Konishi, Yoshiaki Nakayama, Aki Minoda, Ashwin N. Skelly, Yasuhiko Minokoshi, Nicholas Pucci, Daniel R. Mende, Makoto Arita, Hironori Yamamoto, Shunji Watanabe, Kouichi Miura, Scott Behie, Wataru Suda, Toshiro Sato, Koji Atarashi, Mami Matsushita, Shingo Kajimura, Damian R. Plichta, Masayuki Saito, Ramnik J. Xavier, Kenya Honda |
| DOI | 10.1038/s41586-026-10205-3 |
| Journal | Nature |
| Vol/Num/Page | ISSN 1476-4687 (online) |
| Publication Date | 2026 March 4. |
Affiliations:
Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan
Takeshi Tanoue, Manabu Nagayama, Ayumi J. A. Roochana, Satoshi Sasajima, Kozue Takeshita, Ashwin N. Skelly, Koji Atarashi & Kenya Honda
RIKEN Center for Integrative Medical Sciences, Yokohama, JapanTakeshi Tanoue, Manabu Nagayama, Nicola Hetherington, Nobuyuki Okahashi, Masahiro Ueda, Aki Minoda, Makoto Arita, Wataru Suda, Koji Atarashi & Kenya Honda
City of Hope National Medical Center, Duarte, CA, USA
Takeshi Tanoue, Koji Atarashi & Kenya Honda
Division of Gastroenterology, Department of Medicine, Jichi Medical University, Tochigi, Japan
Manabu Nagayama, Hironori Yamamoto, Shunji Watanabe & Kouichi Miura
Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Samuel Zimmerman, Damian R. Plichta & Ramnik J. Xavier
Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA, USA
Orr Ashenberg, Tanvi Jain & Ramnik J. Xavier
Department of Integrated Medicine and Biochemistry, Keio University School of Medicine, Tokyo, Japan
Ryo Igarashi & Toshiro Sato
Department of Human Biology, Radboud Institute for Molecular Life Sciences, Faculty of Science, University of Radboud, Nijmegen, The Netherlands
Nicola Hetherington & Aki Minoda
JSR-Keio University Medical and Chemical Innovation Center, Keio University School of Medicine, Tokyo, Japan
Masahiro Ueda
Laboratory of Microbial Chemistry, Kobe Pharmaceutical University, Kobe, Japan
Morichika Konishi & Yoshiaki Nakayama
Division of Endocrinology and Metabolism, National Institute for Physiological Sciences, Okazaki, Japan
Yasuhiko Minokoshi
Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
Nicholas Pucci & Daniel R. Mende
Human Biology Microbiome Quantum Research Center (WPI-Bio2Q), Keio University, Tokyo, Japan
Daniel R. Mende, Makoto Arita, Scott W. Behie, Toshiro Sato & Koji Atarashi
Division of Physiological Chemistry and Metabolism, Graduate School of Pharmaceutical Sciences, Keio University, Tokyo, Japan
Makoto Arita & Kenya Honda
Department of Nutrition, School of Nursing and Nutrition, Tenshi College, Sapporo, Japan
Mami Matsushita
Division of Endocrinology, Diabetes and Metabolism, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA
Shingo Kajimura
More Bio2Q News
【Nov. 25 Seminar】 WPI-Bio2Q Open Seminar: Xu Zhang, PhD(for Keio Members)
Keio University Human Biology-Microbiome-Quantum Research Center (WPI-Bio2Q) will hold a seminar as follows. This event is only for faculty, students, and staff of Keio University. Date and Time Wednesday, November 25, 2026, 11:00-11:40 Format Zoom (Online only) Title Senescent Cell–Derived Factors Suppress Innate Antiviral Immunity During Aging Speaker Xu Zha...
【Event Report】Bio2Q Participates in the 15th WPI Science Symposium, Engaging wit...
On Saturday, November 14, 2026, the 15th WPI Science Symposium, themed “World Premieres Born from Me! ~Science I Want to Share with Someone~,” was held at the Osaka University Convention Center in Suita, Osaka, hosted by the Osaka University Premium Research Institute for Human Metaverse Medicine (WPI-PRIMe). The event featured a special lecture by Prof. Shimon Sakaguchi (Distinguished University ...
WPI-Bio2Q now recruiting administrative staff– Deadline: January 11, 2027
WPI-Bio2Q Administrative Office is currently hiring administrative staff. We look forward to receiving applications from candidates with English proficiency who can support international researchers and anticipate to work at Bio2Q Administrative Office. Application Deadline: January 11, 2027 For more details, please refer to the application information at the link below, Application Info...
New Long-Term Internship Student-Mr. Kevin Deesy
Introducing a new Long-Term Internship Student of Bio2Q We are delighted to welcome Mr. Kevin Deesy as a new Long-Term Research Internship Student of Bio2Q. "Hello Bio2Q team, My name is Kevin Deesy, and I’m currently completing my Master’s in Sustainable Food at the Technical University of Munich (TUM), specializing in molecular biotechnology and microbiology. My research so far has take...
New Member - Dr. Augustinas Silale
Introducing new member of Bio2Q We are excited to welcome Dr. Augustinas Silale as a Jr. PI at Bio-2 Core of Bio2Q. "Hello, Bio2Q community! My name is Augustinas (August) Silale. I am from Lithuania. I am delighted to join Bio2Q as a Jr. PI. I read Natural Sciences at the University of Cambridge. My BA project was on fragment-based drug discovery in Prof Sir Tom Blundell’s group, where ...

